- Home
- MAIA vs JSPR Comparison
MAIA vs JSPR Comparison
Compare MAIA & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- JSPR
- Stock Information
- Founded
- MAIA 2018
- JSPR 2018
- Country
- MAIA United States
- JSPR United States
- Employees
- MAIA N/A
- JSPR N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAIA Health Care
- JSPR Health Care
- Exchange
- MAIA Nasdaq
- JSPR Nasdaq
- Market Cap
- MAIA 56.7M
- JSPR 68.4M
- IPO Year
- MAIA 2022
- JSPR N/A
- Fundamental
- Price
- MAIA $1.32
- JSPR $2.54
- Analyst Decision
- MAIA
- JSPR Buy
- Analyst Count
- MAIA 0
- JSPR 11
- Target Price
- MAIA N/A
- JSPR $28.00
- AVG Volume (30 Days)
- MAIA 594.6K
- JSPR 443.9K
- Earning Date
- MAIA 11-11-2025
- JSPR 11-06-2025
- Dividend Yield
- MAIA N/A
- JSPR N/A
- EPS Growth
- MAIA N/A
- JSPR N/A
- EPS
- MAIA N/A
- JSPR N/A
- Revenue
- MAIA N/A
- JSPR N/A
- Revenue This Year
- MAIA N/A
- JSPR N/A
- Revenue Next Year
- MAIA N/A
- JSPR N/A
- P/E Ratio
- MAIA N/A
- JSPR N/A
- Revenue Growth
- MAIA N/A
- JSPR N/A
- 52 Week Low
- MAIA $1.27
- JSPR $2.22
- 52 Week High
- MAIA $3.48
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- MAIA 34.23
- JSPR 50.33
- Support Level
- MAIA $1.65
- JSPR $2.41
- Resistance Level
- MAIA $1.97
- JSPR $2.65
- Average True Range (ATR)
- MAIA 0.12
- JSPR 0.15
- MACD
- MAIA -0.05
- JSPR 0.03
- Stochastic Oscillator
- MAIA 4.45
- JSPR 62.50
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.